Gilead Sciences, Inc. (GILD)
151.40
+0.28
(+0.19%)
USD |
NASDAQ |
Feb 20, 16:00
151.49
+0.09
(+0.06%)
After-Hours: 20:00
Gilead Sciences Profit Margin (Quarterly) : 27.55% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Amgen, Inc. | 13.47% |
| Johnson & Johnson | 20.83% |
| Eli Lilly & Co. | 34.40% |
| Regeneron Pharmaceuticals, Inc. | 21.74% |
| Moderna, Inc. | -121.8% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 41.72% |
| Return on Assets | 14.74% |
| Return on Invested Capital | 20.84% |
| Gross Profit Margin (Quarterly) | 86.84% |
| Operating Margin (Quarterly) | 37.40% |
| Return on Net Operating Assets | 21.54% |